subject: DRUGBANK:DB17109


subject: DRUGBANK:DB17109

subject_name: Tegavivint

object_name: Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements

tested_intervention: unsure


subject: DRUGBANK:DB17109

object_name: Refractory High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: DRUGBANK:DB17109

object_name: Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma


subject: DRUGBANK:DB17109

object_name: Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements


subject: DRUGBANK:DB17109

object_name: Recurrent High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements


subject: UMLS:C1569021

subject_name: INGAP peptide

object_name: type 2 diabetes mellitus

tested_intervention: yes


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Cigarette smoker (finding)


subject: PUBCHEM.COMPOUND:76470875

subject_name: Glecaprevir

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:76470875

object_name: coronary atherosclerosis


subject: CHEBI:135919

subject_name: Nesiritide

object_name: cardio-renal syndrome


subject: CHEBI:28645

subject_name: FRUCTOSE

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:28645

object_name: metabolic syndrome X


subject: CHEBI:48095

subject_name: keto-D-fructose


subject: CHEBI:48095


subject: CHEBI:50858

subject_name: corticosteroid

object_name: Adrenal Crisis


subject: CHEBI:50858

object_name: septic shock


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UMLS:C3536709


subject: UMLS:C5908023

subject_name: Autologous KRAS G12D-specific HLA-C*08:02-restricted TCR Gene Engineered T-lymphocytes NT-112

object_name: Adult Solid Neoplasm


subject: UMLS:C5908023


subject: UMLS:C5908023

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5908023

object_name: non-small cell lung carcinoma


subject: UMLS:C5908023

object_name: colorectal carcinoma


subject: UMLS:C5908023

object_name: endometrial cancer


subject: UMLS:C5908023

object_name: uterine corpus cancer


subject: UMLS:C5908023

object_name: endometrial carcinoma


subject: UNII:XCL1K2T28K

object_name: cancer


subject: UNII:XCL1K2T28K

object_name: neoplasm


subject: PUBCHEM.COMPOUND:54592163

object_name: rheumatoid arthritis


subject: GTOPDB:8926

subject_name: glembatumumab vedotin

object_name: squamous cell lung carcinoma


subject: UNII:1568H6A58U


subject: UMLS:C2698156


subject: CHEBI:176724

subject_name: Etiracetam

object_name: psychosis


subject: CHEBI:176724

object_name: Nonorganic psychosis


subject: CHEBI:176724

object_name: Psychosis, CTCAE


subject: CHEBI:176724

object_name: schizoaffective disorder


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Plasma cell tumor, malignant


subject: PUBCHEM.COMPOUND:92043599

object_name: plasma cell neoplasm


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: prostate neoplasm


subject: UMLS:C0599934

subject_name: Vaccines, Peptide


subject: CHEBI:17968

subject_name: butyrate

object_name: Stress


subject: MESH:D002087

subject_name: Butyrates


subject: CHEBI:30772

subject_name: Butyric Acid


subject: CHEBI:600103

subject_name: daptomycin

object_name: infective endocarditis


subject: CHEBI:600103

object_name: bacterial endocarditis


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: ototoxicity


subject: PUBCHEM.COMPOUND:2767

object_name: Primary malignant neoplasm


subject: PUBCHEM.COMPOUND:2767

object_name: childhood malignant neoplasm


subject: PUBCHEM.COMPOUND:2767

object_name: Malignant obstetric neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: urinary system disorder


subject: UNII:8G388563M7

subject_name: Telotristat ethyl

object_name: Pancreatic adenocarcinoma recurrent


subject: UNII:8G388563M7

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:8G388563M7

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:8G388563M7

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:8G388563M7

object_name: Locally Advanced Unresectable Pancreatic Adenocarcinoma


subject: MESH:C551013

subject_name: Grazax

object_name: Allergy to hay


subject: UMLS:C3714111

object_name: skin squamous cell carcinoma


subject: UMLS:C3714111

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C3714111

object_name: trabecular adenocarcinoma


subject: UMLS:C3714111

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C3714111

object_name: melanoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UMLS:C3827082


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: Surgically-Created Resection Cavity


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: peritoneal carcinomatosis


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: CHEBI:229764

subject_name: Selinexor

object_name: neuroendocrine carcinoma


subject: CHEBI:9168

subject_name: Sirolimus

object_name: uterine fibroid


subject: UNII:RC2V4W0EYC

subject_name: Buloxibutid

object_name: interstitial lung disease 1


subject: GTOPDB:7037


subject: GTOPDB:7037

object_name: interstitial lung disease 2


subject: MESH:C121809

subject_name: MT 21

object_name: cystic fibrosis


subject: MESH:C121809

object_name: exocrine pancreatic insufficiency


subject: MESH:C121809

object_name: malabsorption syndrome


subject: MESH:C121809

object_name: steatorrhea


subject: UMLS:C0815017

subject_name: Angiotensin Receptor Antagonists


subject: DRUGBANK:DB16994

object_name: Myasthenia Gravis, Generalized


subject: CHEBI:90841

subject_name: Cangrelor

object_name: Out-of-Hospital Cardiac Arrest


subject: UMLS:C2985201

subject_name: BRAF(V600E) Kinase Inhibitor RO5212054

object_name: neoplasm


subject: UMLS:C3534685

subject_name: Injection, aflibercept, 1 mg administered

object_name: choroid disease


subject: UMLS:C3534685

object_name: choroidal neovascularization


subject: UMLS:C3534685

object_name: choroidal neovascularization (physical finding)


subject: UMLS:C5203181

subject_name: Aflibercept Liquid Injection


subject: UMLS:C5203181


subject: UMLS:C5203181


subject: UNII:15C2VL427D

subject_name: Aflibercept


subject: CHEBI:63610

subject_name: Misoprostol

object_name: Pathological Dilatation


subject: CHEBI:63610

object_name: Distention


subject: CHEBI:63610

object_name: Constipation


subject: CHEBI:63610

object_name: Constipation, CTCAE


subject: CHEBI:63610

object_name: gas bloat syndrome


subject: UMLS:C0359953

subject_name: bupivacaine / epinephrine

object_name: Nasal Polyp


subject: UMLS:C0359953

object_name: Deviated nasal septum


subject: UMLS:C0359953

object_name: chronic rhinosinusitis


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Advanced Hepatocellular Carcinoma


subject: CHEBI:600103

subject_name: daptomycin

object_name: gram-positive bacterial infections


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: Vomiting, Postoperative


subject: CHEBI:50731

object_name: Postoperative Nausea


subject: CHEBI:50731

object_name: Pruritus, CTCAE


subject: CHEBI:50731

object_name: Pruritus


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: UNII:9G2MP84A8W

object_name: Neck Carcinoma


subject: UNII:9G2MP84A8W

object_name: head and neck neoplasm


subject: UNII:9G2MP84A8W

object_name: head and neck cancer


subject: UNII:9G2MP84A8W

object_name: pancreatic neoplasm


subject: UNII:9G2MP84A8W

object_name: exocrine pancreatic carcinoma


subject: UNII:9G2MP84A8W

object_name: malignant pancreatic neoplasm


subject: UNII:9G2MP84A8W

object_name: Stomach cancer


subject: UNII:9G2MP84A8W

object_name: gastric cancer


subject: UNII:9G2MP84A8W

object_name: Childhood Breast Carcinoma


subject: UNII:9G2MP84A8W

object_name: breast carcinoma


subject: UNII:9G2MP84A8W

object_name: breast cancer


subject: UNII:9G2MP84A8W

object_name: lung cancer


subject: UNII:9G2MP84A8W

object_name: lung neoplasm


subject: UNII:9G2MP84A8W

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:40


subject: PUBCHEM.COMPOUND:40


subject: PUBCHEM.COMPOUND:40


subject: PUBCHEM.COMPOUND:40


subject: PUBCHEM.COMPOUND:40


subject: PUBCHEM.COMPOUND:40


subject: PUBCHEM.COMPOUND:40


subject: PUBCHEM.COMPOUND:40


subject: PUBCHEM.COMPOUND:40


subject: PUBCHEM.COMPOUND:40


subject: PUBCHEM.COMPOUND:40


subject: PUBCHEM.COMPOUND:40


subject: PUBCHEM.COMPOUND:40


subject: PUBCHEM.COMPOUND:40


subject: CHEBI:84755

subject_name: Deoxyglucose


subject: CHEBI:84755


subject: CHEBI:84755


subject: CHEBI:84755


subject: CHEBI:84755


subject: CHEBI:84755


subject: CHEBI:84755


subject: CHEBI:84755


subject: CHEBI:84755


subject: CHEBI:84755


subject: CHEBI:84755


subject: CHEBI:84755


subject: CHEBI:84755


subject: CHEBI:84755


subject: CHEBI:15866


subject: CHEBI:15866


subject: CHEBI:15866


subject: CHEBI:15866


subject: CHEBI:15866


subject: CHEBI:15866


subject: CHEBI:15866


subject: CHEBI:15866


subject: CHEBI:15866


subject: CHEBI:15866


subject: CHEBI:15866


subject: CHEBI:15866


subject: CHEBI:15866


subject: CHEBI:15866


subject: UMLS:C5888711

subject_name: gabapentin topical

object_name: Pseudopelade


subject: UMLS:C5888711

object_name: frontal fibrosing alopecia


subject: UMLS:C5888711

object_name: central centrifugal cicatricial alopecia


subject: UMLS:C5888711

object_name: lichen planopilaris


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: HIV-1 infection


subject: UMLS:C1098513


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:PVI5M0M1GW

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:PVI5M0M1GW

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:PVI5M0M1GW

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:PVI5M0M1GW

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:PVI5M0M1GW

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:PVI5M0M1GW

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:PVI5M0M1GW

object_name: Stage IIIB Breast Carcinoma


subject: UNII:PVI5M0M1GW

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:PVI5M0M1GW

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: autoimmune disease, multisystem, infantile-onset, 2


subject: UMLS:C0003442

object_name: Autoimmunity


subject: UMLS:C0003442

object_name: autoimmune disorder of the nervous system


subject: UMLS:C0003442

object_name: central nervous system vasculitis


subject: UMLS:C0003442

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: UMLS:C0003442

object_name: Guillain-Barre syndrome, familial


subject: UMLS:C0003442

object_name: opsoclonus-myoclonus syndrome


subject: UMLS:C0003442

object_name: Lambert-Eaton myasthenic syndrome


subject: UMLS:C0003442

object_name: cerebellar degeneration


subject: UMLS:C0003442

object_name: Rasmussen subacute encephalitis


subject: UMLS:C0003442

object_name: neuromyelitis optica


subject: UMLS:C0003442

object_name: stiff-person syndrome


subject: CHEBI:3423

subject_name: Carmustine


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423


subject: CHEBI:3423

object_name: myasthenia gravis


subject: CHEBI:3423

object_name: Myasthenia Gravis, CTCAE


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: UNII:45X7OU8C4J

subject_name: DOMVANALIMAB

object_name: glioblastoma


subject: UNII:45X7OU8C4J

object_name: Childhood Glioblastoma


subject: UNII:45X7OU8C4J

object_name: adult glioblastoma


subject: UMLS:C5206853

subject_name: Domvanalimab


subject: UMLS:C5206853


subject: UMLS:C5206853


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5565989

object_name: Alzheimer disease type 1


subject: UMLS:C5565989

object_name: Alzheimer disease


subject: UMLS:C5442040

object_name: neoplasm


subject: CHEBI:6801

subject_name: Metformin

object_name: hyperemesis gravidarum


subject: UNII:06P3KLK2J8

subject_name: Glofitamab

object_name: primary central nervous system lymphoma


subject: UNII:06P3KLK2J8

object_name: Secondary Central Nervous System Lymphoma


subject: UMLS:C4725069

subject_name: glofitamab


subject: UMLS:C4725069


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: atrial septal defect


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: PUBCHEM.COMPOUND:77014446

subject_name: Ketofol


subject: PUBCHEM.COMPOUND:77014446

object_name: heart valve disorder


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: UMLS:C4743433

subject_name: onabotulinum toxin A

object_name: Stress urinary incontinence


subject: CHEBI:73757

subject_name: Ala-Gly

object_name: Malignant neoplasm of pancreas resectable


subject: CHEBI:193565


subject: CHEBI:73836

subject_name: D-Ala-Gly


subject: UMLS:C1370189

subject_name: Pneumocystis jiroveci antigen


subject: CHEBI:27569

subject_name: arabinogalactan


subject: MESH:D019081

subject_name: O Antigens


subject: MESH:D000941

subject_name: Antigens


subject: UMLS:C0808086

subject_name: Streptococcus pneumoniae group B Antigen


subject: UMLS:C0808084

subject_name: Streptococcus pneumoniae group A Antigen


subject: UMLS:C1545907

subject_name: A variant not otherwise specified Antigen


subject: CHEBI:2654

subject_name: Aminoglutethimide


subject: CHEBI:30512

subject_name: Silver


subject: CHEBI:73788

subject_name: Ala-Gln


subject: CHEBI:49468

subject_name: Silver cation


subject: CHEBI:40618

subject_name: Pimagedine


subject: PR:000004168

subject_name: amyloid-beta precursor protein


subject: UMLS:C0243192

subject_name: agonists


subject: GTOPDB:7988

subject_name: nimotuzumab


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Fracture of shaft of femur


subject: CHEBI:94807

subject_name: Nitazoxanide

object_name: viral pneumonia


subject: CHEBI:30089

subject_name: Acetate

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:30089

object_name: obesity


subject: CHEBI:30089

object_name: Obesity, CTCAE


subject: CHEBI:47622

subject_name: acetate ester


subject: CHEBI:47622


subject: CHEBI:47622


subject: CHEBI:40410

subject_name: N-acetylglycine


subject: CHEBI:40410


subject: CHEBI:40410


subject: CHEBI:15366

subject_name: Acetic acid


subject: CHEBI:15366


subject: CHEBI:15366


subject: CHEBI:52051

subject_name: benzyl acetate


subject: CHEBI:52051


subject: CHEBI:52051


subject: UMLS:C2945718

subject_name: Lupin protein

object_name: glucose metabolism disease


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:71226663

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:71226663

object_name: ovarian carcinoma


subject: CHEBI:90936

subject_name: Alectinib

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:5959

subject_name: Irbesartan

object_name: chronic hepatitis C virus infection


subject: CHEBI:35476

subject_name: antipsychotic agent

object_name: schizophrenia


subject: CHEBI:16118

subject_name: Berberine

object_name: Androgen excess


subject: CHEBI:90926

subject_name: Tenofovir alafenamide

object_name: Liver transplant disorder


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Melasma


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Labor Pain


subject: GTOPDB:4996

object_name: Hand wart


subject: GTOPDB:4996

object_name: Genital warts


subject: PR:000001391


subject: PR:000001391


subject: UMLS:C1522540

subject_name: Recombinant Interleukin-4


subject: UMLS:C1522540


subject: UMLS:C3486572

subject_name: binetrakin


subject: UMLS:C3486572


subject: CHEBI:101278

subject_name: Diltiazem

object_name: rapid ventricular response


subject: CHEBI:101278

object_name: atrial flutter


subject: CHEBI:101278

object_name: Atrial Flutter by ECG Finding


subject: CHEBI:101278

object_name: Atrial Flutter, CTCAE


subject: CHEBI:9907

subject_name: ursodiol

object_name: autoimmune hepatitis


subject: CHEBI:16664

subject_name: Albendazole

object_name: toxocariasis


subject: CHEBI:4856

subject_name: Esmolol

object_name: Deviated nasal septum


subject: CHEBI:36088

subject_name: thromboxanes A

object_name: Intraoperative Hemorrhage


subject: PUBCHEM.COMPOUND:11979741

subject_name: syntometrine

object_name: postpartum hemorrhage


subject: PUBCHEM.COMPOUND:11979741

object_name: Post-partum hemorrhage


subject: PUBCHEM.COMPOUND:11979741

object_name: Blood Loss


subject: PUBCHEM.COMPOUND:11979741

object_name: Hemorrhage


subject: UMLS:C0075707


subject: UMLS:C0075707


subject: UMLS:C0075707


subject: UMLS:C0075707


subject: CHEBI:59204

subject_name: Carbetocin


subject: CHEBI:59204


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: substance abuse


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: Stage III Colon Cancer


subject: UMLS:C4287697


subject: MESH:D004043

subject_name: Dietary Fiber

object_name: cerebral palsy


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: Pleural mesothelioma malignant recurrent


subject: PUBCHEM.COMPOUND:135423438

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v7


subject: CHEBI:85164


subject: CHEBI:85164


subject: UMLS:C5667102

subject_name: EGFR Ex20ins Inhibitor BLU-451

object_name: EGFR Exon 20 Insertion Mutation


subject: UMLS:C5667102

object_name: EGFR Exon 20 Mutation


subject: UMLS:C5667102

object_name: Activating EGFR Gene Mutation


subject: UMLS:C5667102

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C5667102

object_name: respiratory tract neoplasm


subject: UMLS:C5667102

object_name: Neoplasms by Histologic Type


subject: UMLS:C5667102

object_name: respiratory system disorder


subject: UMLS:C5667102

object_name: non-small cell lung carcinoma


subject: UMLS:C5667102

object_name: lung cancer


subject: UMLS:C5667102

object_name: bronchogenic carcinoma


subject: UMLS:C5667102

object_name: bronchial neoplasm


subject: UMLS:C5667102

object_name: cancer


subject: UMLS:C5667102

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C5667102

object_name: esophageal adenocarcinoma


subject: UMLS:C5667102

object_name: lung adenocarcinoma


subject: UMLS:C5667102

object_name: cervical adenocarcinoma


subject: UMLS:C5667102

object_name: adenocarcinoma


subject: UMLS:C5667102

object_name: bile duct adenocarcinoma


subject: UMLS:C5667102

object_name: gastric adenocarcinoma


subject: UMLS:C5667102

object_name: lung disorder


subject: UMLS:C5667102

object_name: neoplasm


subject: UMLS:C5667102

object_name: carcinoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: EGFR Exon 20 Insertion Mutation


subject: CHEBI:31355

object_name: EGFR Exon 20 Mutation


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021

object_name: respiratory tract neoplasm


subject: CHEBI:95021

object_name: respiratory system disorder


subject: CHEBI:95021

object_name: bronchogenic carcinoma


subject: CHEBI:95021

object_name: bronchial neoplasm


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724

object_name: Neoplasms by Histologic Type


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: UMLS:C0123759

object_name: glioblastoma


subject: UMLS:C0123759

object_name: Childhood Glioblastoma


subject: UMLS:C0123759

object_name: adult glioblastoma


subject: UMLS:C0123759

object_name: glioma


subject: UMLS:C0123759

object_name: malignant glioma


subject: UMLS:C0123759

object_name: neuroepithelial neoplasm


subject: UMLS:C0123759

object_name: primitive neuroectodermal tumor


subject: UMLS:C0123759

object_name: peripheral primitive neuroectodermal tumor


subject: UMLS:C0123759

object_name: nervous system cancer


subject: UMLS:C0123759

object_name: neoplasm


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: UMLS:C5448047

subject_name: STP 705

object_name: cholangiocarcinoma


subject: UMLS:C5448047

object_name: liver carcinoma


subject: UMLS:C5448047

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:3395

subject_name: carbidopa

object_name: major depressive disorder


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:36704

subject_name: Imiquimod

object_name: Immunization reaction


subject: CHEBI:36704

object_name: Vaccination failure


subject: CHEBI:36704

object_name: hepatitis B


subject: CHEBI:36704

object_name: liver cirrhosis


subject: UMLS:C4704928

subject_name: Antibody-Drug Conjugates

object_name: cancer


subject: UMLS:C4704928


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:74947

subject_name: Thalidomide

object_name: precancerous condition


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: nephroblastoma


subject: UNII:PVI5M0M1GW

object_name: Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UNII:PVI5M0M1GW

object_name: childhood choroid plexus neoplasm


subject: UNII:PVI5M0M1GW

object_name: Childhood Soft Tissue Sarcoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: MESH:C511203

subject_name: COLD-fX

object_name: Upper Respiratory Infections


subject: MESH:C511203

object_name: Upper Respiratory Infection, CTCAE


subject: UNII:JGK960078D

subject_name: Ferronord

object_name: Heart failure with normal ejection fraction


subject: UNII:JGK960078D

object_name: iron deficiency anemia


subject: CHEMBL.COMPOUND:CHEMBL4297671

subject_name: FERROGLYCINE SULFATE


subject: CHEMBL.COMPOUND:CHEMBL4297671


subject: MESH:C000718012

subject_name: sucrosomial iron


subject: UMLS:C5544915


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Allergic rhinitis caused by grass pollen


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:34730

subject_name: doxycycline hyclate

object_name: hyperthyroidism


subject: CHEBI:34730

object_name: Hyperthyroidism, CTCAE


subject: CHEBI:34730

object_name: thyroid disease


subject: CHEBI:34730

object_name: endocrine system disorder


subject: CHEBI:34730

object_name: Eye Diseases, Hereditary


subject: CHEBI:34730

object_name: immune system disorder


subject: CHEBI:34730

object_name: Autoimmunity


subject: CHEBI:34730

object_name: Graves disease


subject: UNII:89FYR7JU5A

object_name: type 2 diabetes mellitus


subject: UMLS:C3714136


subject: UNII:TUK9QB44B0

object_name: inflammatory bowel disease


subject: UMLS:C5392518


subject: UMLS:C5708964

subject_name: HM-30181 Methanesulfonate Monohydrate

object_name: Childhood Solid Neoplasm


subject: UMLS:C5708964

object_name: Adult Solid Neoplasm


subject: UMLS:C5708964

object_name: Solid Neoplasm


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Acute HIV infection


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist

object_name: Pediatric Obesity


subject: UMLS:C2917359

subject_name: GLP-1 Receptor Agonist [EPC]


subject: CHEBI:31632

subject_name: Decasodium salt

object_name: Superficial vein thrombosis


subject: UMLS:C1145196

subject_name: INJECTION, FONDAPARINUX SODIUM, 0.5 MG ADMINISTERED


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: sarcoidosis


subject: CHEBI:41879

object_name: sarcoidosis, susceptibility to, 1


subject: UNII:7CND0TX59N

subject_name: Potassium octanoate

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:25646

subject_name: octanoate


subject: CHEBI:28837

subject_name: Caprylic acid


subject: CHEBI:8382

subject_name: Prednisone

object_name: Hyperuricemia


subject: CHEBI:8382

object_name: Hyperuricemia, CTCAE


subject: CHEBI:209807

subject_name: Cefoxitin

object_name: urinary tract infection


subject: CHEBI:209807

object_name: Recurrent urinary tract infections


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain

object_name: Critical Illness


subject: UMLS:C0002521

object_name: Muscle Atrophy


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Adverse effects in the therapeutic use of anticoagulants


subject: CHEBI:70746

object_name: Poisoning by, adverse effect of and underdosing of anticoagulants


subject: CHEBI:70746

object_name: Poisoning by anticoagulant


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:82339

subject_name: Merphalan

object_name: retina neoplasm


subject: CHEBI:28876

subject_name: Melphalan


subject: UMLS:C0733688

object_name: retinoblastoma


subject: UMLS:C0733688


subject: CHEBI:94782

subject_name: Cediranib

object_name: metastatic colorectal cancer


subject: MESH:C000730795

object_name: Hemodynamic instability


subject: DRUGBANK:DB19248

subject_name: Bifidobacterium longum

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB19248

object_name: obesity


subject: DRUGBANK:DB19248

object_name: Obesity, CTCAE


subject: UMLS:C0873126

subject_name: borage extract

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C0873126

object_name: metabolic syndrome X


subject: UMLS:C0873126

object_name: type 2 diabetes mellitus


subject: UMLS:C0873126

object_name: Diabetes


subject: UMLS:C0873126

object_name: diabetes mellitus


subject: UMLS:C1256263

subject_name: Borago officinalis, flower essence


subject: UMLS:C1256263


subject: UMLS:C1256263


subject: UMLS:C1256263


subject: UMLS:C1256263


subject: UMLS:C1258613

subject_name: oblimersen sodium

object_name: primary cutaneous B-cell lymphoma


subject: UMLS:C1258613

object_name: testicular lymphoma


subject: UMLS:C1258613

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C1258613

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C1258613

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C1258613

object_name: intraocular lymphoma


subject: UMLS:C1258613

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UMLS:C1258613

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C1258613

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C1258613

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C1258613

object_name: small intestine lymphoma


subject: UMLS:C1258613

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C1258613

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UMLS:C1258613

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C1258613

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: UMLS:C1258613

object_name: MALT lymphoma


subject: UMLS:C1258613

object_name: splenic marginal zone lymphoma


subject: UNII:889I657R9P

subject_name: Desmethylsibutramine

object_name: Androgen excess


subject: UNII:987R943R3P

subject_name: Didesmethylsibutramine


subject: CHEBI:9137

subject_name: Sibutramine


subject: CHEBI:4464

subject_name: Dexchlorpheniramine

object_name: prostate carcinoma


subject: CHEBI:4464

object_name: prostate cancer


subject: CHEBI:107736

subject_name: Metoclopramide


subject: CHEBI:107736


subject: CHEBI:184693

subject_name: GRANISETRON


subject: CHEBI:184693


subject: UNII:884KT10YB7

subject_name: (Z)-ranitidine


subject: UNII:884KT10YB7


subject: CHEBI:8776

subject_name: ranitidine


subject: CHEBI:8776


subject: CHEBI:41423

subject_name: Celecoxib

object_name: stage, colon cancer


subject: CHEBI:51380

subject_name: Doxylamine

object_name: pregnancy related


subject: CHEBI:51380

object_name: Nausea, CTCAE_5


subject: CHEBI:51380

object_name: Nausea


subject: CHEBI:51380

object_name: Nausea, CTCAE_3


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class


subject: UMLS:C3714638


subject: UMLS:C3714638


subject: UMLS:C3714638


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:27306


subject: CHEBI:27306


subject: CHEBI:27306


subject: CHEBI:230470

subject_name: rezafungin acetate

object_name: Chronic pulmonary aspergillosis


subject: UNII:W1U1TMN677

subject_name: Biafungin acetate


subject: CHEBI:229680

subject_name: Rezafungin


subject: UMLS:C2698142

object_name: liver carcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: lip and oral cavity carcinoma


subject: CHEBI:6801

object_name: oral cavity cancer


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Unspecified complication of liver transplant


subject: UNII:82MI0GT75Z

object_name: cysticercosis


subject: UNII:82MI0GT75Z

object_name: Neurocysticercosis


subject: UNII:82MI0GT75Z

object_name: Central Nervous System Cysticercosis


subject: MESH:C526315


subject: MESH:C526315


subject: MESH:C526315


subject: PUBCHEM.COMPOUND:3367

object_name: B-CELL MALIGNANCY, LOW-GRADE


subject: PUBCHEM.COMPOUND:3367

object_name: leukemia, chronic lymphocytic, susceptibility to, 2


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:91397

subject_name: Ibrutinib


subject: CHEBI:91397


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: CHEBI:132922

object_name: spinal cord injury


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UMLS:C1174783

subject_name: Zarnestra

object_name: glioblastoma


subject: UMLS:C1174783

object_name: Brain Stem Glioblastoma


subject: UMLS:C1174783

object_name: glioma susceptibility 1


subject: CHEBI:87681

subject_name: Ranolazine

object_name: cardiomyopathy


subject: PR:000002122

subject_name: C-C motif chemokine 2

object_name: rubella


subject: PR:000002122

object_name: Japanese encephalitis


subject: PR:000002122

object_name: measles


subject: CHEBI:10033

subject_name: Warfarin

object_name: prostate carcinoma


subject: CHEBI:10033

object_name: prostate cancer


subject: CHEBI:44975

subject_name: PHENANTHROLINE

object_name: binge eating


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: CHEBI:43636

object_name: ovarian hyperstimulation syndrome


subject: CHEBI:43636

object_name: female infertility


subject: UNII:4O2AB118LA

subject_name: GRAZOPREVIR

object_name: HIV infection


subject: UMLS:C0721124

subject_name: Iron Supplement

object_name: Hemoglobin finding


subject: UMLS:C0721124

object_name: Hemoglobin, CTCAE


subject: UMLS:C0721124

object_name: hemoglobin measurement


subject: UMLS:C2825025

subject_name: Iron Supplement [EPC]


subject: UMLS:C2825025


subject: UMLS:C2825025


subject: UNII:S3OPE9IA3Q

object_name: Solid Neoplasm


subject: CHEBI:180905

subject_name: Nicardipine

object_name: stroke disorder


subject: CHEBI:180905

object_name: cerebrovascular disorder


subject: CHEBI:180905

object_name: Stroke (heart beat)


subject: CHEBI:180905

object_name: Stroke, CTCAE


subject: CHEBI:46245

subject_name: Ubidecarenone

object_name: Becker muscular dystrophy


subject: CHEBI:46245

object_name: limb-girdle muscular dystrophy


subject: CHEBI:6503

subject_name: LISINOPRIL

object_name: Duchenne muscular dystrophy


subject: CHEBI:6503


subject: CHEBI:6503


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: CHEBI:43755


subject: CHEBI:188559

subject_name: Palovarotene

object_name: dry eye syndrome


subject: CHEBI:15891

subject_name: Taurine

object_name: Increased reactive oxygen species production


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: biliary tract cancer


subject: PR:000005931


subject: UMLS:C0540212

object_name: inherited lipid metabolism disorder


subject: UMLS:C0540212

object_name: Dyslipidemia


subject: PUBCHEM.COMPOUND:134156320

subject_name: GLUCOSAMINE SULFATE POTASSIUM CHLORIDE

object_name: osteoarthritis, knee


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Kinetic tremor


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: CHEBI:176839

subject_name: vitamin B3

object_name: Oral Mucositis


subject: CHEBI:176839

object_name: stomatitis


subject: CHEBI:176839

object_name: oral mucositis


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:15940


subject: CHEBI:15940


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:17154


subject: CHEBI:17154


subject: PUBCHEM.COMPOUND:3962

object_name: melanoma


subject: CHEBI:40303

subject_name: Lovastatin


subject: UMLS:C4045974

subject_name: Biosimilars

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C5222418

subject_name: Desmopressin Acetate Liquid Injection

object_name: Idiopathic scoliosis and kyphoscoliosis


subject: UMLS:C5222418

object_name: idiopathic scoliosis


subject: PUBCHEM.COMPOUND:16051933

subject_name: DESMOPRESSIN


subject: PUBCHEM.COMPOUND:16051933


subject: UMLS:C5666891

subject_name: ATI 450

object_name: Acne inversa


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: UNII:97IQ273H4L

subject_name: Fostemsavir

object_name: Heart Disease Risk Factors


subject: UMLS:C4043174

object_name: rheumatoid arthritis


subject: UMLS:C4043174

object_name: Inflammation


subject: CHEBI:567361

subject_name: Cladribine

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:567361

object_name: childhood myelodysplastic syndrome


subject: CHEBI:567361

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:567361

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:567361

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:567361

object_name: Blasts 10 Percent or More of Peripheral Blood White Cells


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:145372

subject_name: Gilteritinib

object_name: Myelodysplasia


subject: CHEBI:145372


subject: CHEBI:145372


subject: CHEBI:145372


subject: CHEBI:145372

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:145372

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:145372

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:145372

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:145372

object_name: Blast Phase


subject: CHEBI:145372


subject: CHEBI:145372


subject: CHEBI:145372

object_name: acute biphenotypic leukemia


subject: CHEBI:145372

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:145372


subject: CHEBI:145372

object_name: Blasts 10 Percent or More of Bone Marrow Nucleated Cells


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:91464


subject: CHEBI:91464

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:91464

object_name: Refractory acute myeloid leukemia


subject: CHEBI:91464


subject: CHEBI:91464


subject: CHEBI:91464


subject: CHEBI:91464


subject: CHEBI:91464


subject: CHEBI:91464


subject: CHEBI:91464


subject: CHEBI:91464


subject: CHEBI:63452

subject_name: Midostaurin


subject: CHEBI:63452


subject: CHEBI:63452


subject: CHEBI:63452


subject: CHEBI:63452


subject: CHEBI:63452


subject: CHEBI:63452


subject: CHEBI:63452


subject: CHEBI:63452


subject: CHEBI:63452


subject: CHEBI:63452


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: CHEBI:133021


subject: UNII:M487QF2F4V

subject_name: AMIFOSTINE

object_name: colorectal cancer


subject: UNII:M487QF2F4V

object_name: colorectal carcinoma


subject: UNII:M487QF2F4V

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1321603

subject_name: INJECTION, AMIFOSTINE, 500 MG ADMINISTERED


subject: UMLS:C1321603


subject: UMLS:C1321603


subject: CHEBI:2636

subject_name: Amifostine


subject: CHEBI:2636


subject: CHEBI:2636


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Stage IIIB Lung Cancer AJCC v7


subject: UNII:52CMI0WC3Y

object_name: Stage IIIA Lung Cancer AJCC v7


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:16796

subject_name: Melatonin

object_name: Stress


subject: CHEBI:17688

subject_name: Nicotine

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: CHEBI:32019

subject_name: Piromidic acid

object_name: respiratory tract infectious disorder


subject: CHEBI:133659

subject_name: Pro-Ala


subject: CHEBI:33386

subject_name: Protactinium


subject: CHEBI:30745

subject_name: Phenylacetic acid


subject: CHEBI:8428

subject_name: Procainamide


subject: CHEBI:7959

subject_name: Penicillamine


subject: CHEBI:16335

subject_name: Adenosine


subject: CHEBI:30768

subject_name: Propanoic acid


subject: PR:000049747

subject_name: influenzavirus PA gene translation product


subject: PR:000004008

subject_name: alpha-amylase 2A


subject: PR:000012849

subject_name: biogenesis of lysosome-related organelles complex 1 subunit 6


subject: PR:000013209

subject_name: salivary acidic proline-rich phosphoprotein


subject: UMLS:C2608641

object_name: Adverse reaction to smallpox vaccine


subject: CHEBI:18216

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:18216

object_name: Childhood Breast Carcinoma


subject: CHEBI:18216

object_name: breast carcinoma


subject: CHEBI:18216

object_name: breast cancer


subject: CHEBI:18216

object_name: Cognitive impairment


subject: CHEBI:18216

object_name: Adverse effect of radiation therapy


subject: CHEBI:18216

object_name: GM1 gangliosidosis


subject: PUBCHEM.COMPOUND:20057296

subject_name: Ganglioside GM1 (18:1/16:0)


subject: PUBCHEM.COMPOUND:20057296


subject: PUBCHEM.COMPOUND:20057296


subject: PUBCHEM.COMPOUND:20057296


subject: PUBCHEM.COMPOUND:20057296


subject: PUBCHEM.COMPOUND:20057296


subject: PUBCHEM.COMPOUND:20057296


subject: PUBCHEM.COMPOUND:20057300


subject: PUBCHEM.COMPOUND:20057300


subject: PUBCHEM.COMPOUND:20057300


subject: PUBCHEM.COMPOUND:20057300


subject: PUBCHEM.COMPOUND:20057300


subject: PUBCHEM.COMPOUND:20057300


subject: PUBCHEM.COMPOUND:20057300


subject: CHEBI:177678

subject_name: Ganglioside GM1 (18:1/12:0)


subject: CHEBI:177678


subject: CHEBI:177678


subject: CHEBI:177678


subject: CHEBI:177678


subject: CHEBI:177678


subject: CHEBI:177678


subject: PUBCHEM.COMPOUND:20057297

subject_name: Sygen


subject: PUBCHEM.COMPOUND:20057297


subject: PUBCHEM.COMPOUND:20057297


subject: PUBCHEM.COMPOUND:20057297


subject: PUBCHEM.COMPOUND:20057297


subject: PUBCHEM.COMPOUND:20057297


subject: PUBCHEM.COMPOUND:20057297


subject: PUBCHEM.COMPOUND:20057299

subject_name: Ganglioside GM1 (18:1/22:0)


subject: PUBCHEM.COMPOUND:20057299


subject: PUBCHEM.COMPOUND:20057299


subject: PUBCHEM.COMPOUND:20057299


subject: PUBCHEM.COMPOUND:20057299


subject: PUBCHEM.COMPOUND:20057299


subject: PUBCHEM.COMPOUND:20057299


subject: PUBCHEM.COMPOUND:20057301


subject: PUBCHEM.COMPOUND:20057301


subject: PUBCHEM.COMPOUND:20057301


subject: PUBCHEM.COMPOUND:20057301


subject: PUBCHEM.COMPOUND:20057301


subject: PUBCHEM.COMPOUND:20057301


subject: PUBCHEM.COMPOUND:20057301


subject: CHEBI:177701

subject_name: Ganglioside GM1 (18:1/9Z-18:1)


subject: CHEBI:177701


subject: CHEBI:177701


subject: CHEBI:177701


subject: CHEBI:177701


subject: CHEBI:177701


subject: CHEBI:177701


subject: PUBCHEM.COMPOUND:20057303

subject_name: Ganglioside GM1 (d18:1/24:0)


subject: PUBCHEM.COMPOUND:20057303


subject: PUBCHEM.COMPOUND:20057303


subject: PUBCHEM.COMPOUND:20057303


subject: PUBCHEM.COMPOUND:20057303


subject: PUBCHEM.COMPOUND:20057303


subject: PUBCHEM.COMPOUND:20057303


subject: CHEBI:73110

subject_name: ganglioside GM1(1-)


subject: CHEBI:73110


subject: CHEBI:73110


subject: CHEBI:73110


subject: CHEBI:73110


subject: CHEBI:73110


subject: CHEBI:73110


subject: CHEBI:61048

subject_name: Ganglioside GM1


subject: CHEBI:61048


subject: CHEBI:61048


subject: CHEBI:61048


subject: CHEBI:61048


subject: CHEBI:61048


subject: CHEBI:61048


subject: PUBCHEM.COMPOUND:20057298

subject_name: Ganglioside GM1 (18:1/20:0)


subject: PUBCHEM.COMPOUND:20057298


subject: PUBCHEM.COMPOUND:20057298


subject: PUBCHEM.COMPOUND:20057298


subject: PUBCHEM.COMPOUND:20057298


subject: PUBCHEM.COMPOUND:20057298


subject: PUBCHEM.COMPOUND:20057298


subject: PUBCHEM.COMPOUND:22833613

subject_name: Ganglioside GM1 (d18:1/25:0)


subject: PUBCHEM.COMPOUND:22833613


subject: PUBCHEM.COMPOUND:22833613


subject: PUBCHEM.COMPOUND:22833613


subject: PUBCHEM.COMPOUND:22833613


subject: PUBCHEM.COMPOUND:22833613


subject: PUBCHEM.COMPOUND:22833613


subject: PUBCHEM.COMPOUND:20057302

subject_name: Ganglioside GM1 (d18:1/26:0)


subject: PUBCHEM.COMPOUND:20057302


subject: PUBCHEM.COMPOUND:20057302


subject: PUBCHEM.COMPOUND:20057302


subject: PUBCHEM.COMPOUND:20057302


subject: PUBCHEM.COMPOUND:20057302


subject: PUBCHEM.COMPOUND:20057302


subject: UNII:B669M62ELP

subject_name: MRX-I

object_name: meningitis


subject: UNII:B669M62ELP

object_name: Meningitis, CTCAE


subject: CHEBI:4875

subject_name: Etanercept

object_name: pneumonia


subject: CHEBI:4875

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:4875

object_name: ichthyosis prematurity syndrome


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: PR:000001959


subject: CHEBI:80308

subject_name: substance P

object_name: diarrhea


subject: CHEBI:80308

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:80308

object_name: Diarrhea, CTCAE


subject: UNII:PY79D6C8RX

subject_name: Crofelemer


subject: UNII:PY79D6C8RX


subject: UNII:PY79D6C8RX


subject: CHEMBL.COMPOUND:CHEMBL5095362

subject_name: VOLRUSTOMIG

object_name: metastatic colorectal cancer


subject: UMLS:C5417881

subject_name: Volrustomig


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: heart failure


subject: PUBCHEM.COMPOUND:155543961

object_name: hyperglycemia


subject: PUBCHEM.COMPOUND:155543961

object_name: Hyperglycemia, CTCAE


subject: PUBCHEM.COMPOUND:155543961

object_name: Glucose in blood specimen above reference range


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: PUBCHEM.COMPOUND:4253

subject_name: (-)-Morphine

object_name: Laceration of perineum


subject: PUBCHEM.COMPOUND:5479215

subject_name: (+)-Morphine


subject: UNII:A14FB57V1D

subject_name: GLYCOPYRRONIUM

object_name: post operative nausea and vomiting


subject: GTOPDB:12966

subject_name: cadonilimab


subject: GTOPDB:12966

object_name: gastric adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: GTOPDB:13396

subject_name: ivonescimab


subject: GTOPDB:13396


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C5669600


subject: PR:000013574

subject_name: sulfhydryl oxidase 1


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: pneumococcal infection


subject: CHEMBL.COMPOUND:CHEMBL1742999

subject_name: CARLUMAB

object_name: prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1742999

object_name: prostate cancer


subject: UMLS:C2346793

subject_name: carlumab


subject: UMLS:C2346793


subject: UNII:IT063R5MY0

subject_name: Eptotermin alfa

object_name: osteoarthritis, knee


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: substance-related disorder


subject: UMLS:C3854029

object_name: Binge Drinking


subject: UMLS:C3854029

object_name: Binge drinking


subject: UMLS:C3854029

object_name: Toxic effect of ethyl alcohol


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: UMLS:C3854030


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:9468

subject_name: Tetracaine

object_name: Labor Pain


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Pharmacogenomic drug interaction


subject: CHEBI:31348

subject_name: Capecitabine

object_name: FGFR2 Gene Amplification


subject: CHEBI:31348

object_name: CD274 Gene Amplification


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:6931

subject_name: Midazolam

object_name: Inflammatory disorder of immune system


subject: CHEBI:58097

object_name: Sepsis


subject: CHEBI:58097

object_name: Sepsis, CTCAE


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:8988

object_name: breast neoplasm


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:4875

subject_name: Etanercept

object_name: psoriasis vulgaris


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: UMLS:C4056500

subject_name: soluble corn fiber

object_name: rectal carcinoma


subject: UMLS:C4056500

object_name: rectal cancer


subject: UMLS:C4056500

object_name: Childhood Rectal Carcinoma


subject: DRUGBANK:DB15786

subject_name: Maritime pine extract

object_name: persian gulf syndrome


subject: UMLS:C0072642

subject_name: Pycnogenol


subject: CHEBI:75551


subject: UNII:ZT62XSC86F

subject_name: EVALSTOTUG

object_name: head and neck squamous cell carcinoma


subject: UNII:ZT62XSC86F

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UNII:ZT62XSC86F

object_name: Neck Carcinoma


subject: UNII:ZT62XSC86F

object_name: head and neck neoplasm


subject: UNII:ZT62XSC86F

object_name: head and neck cancer


subject: UNII:ZT62XSC86F

object_name: Disseminated Malignant Neoplasm


subject: UNII:ZT62XSC86F

object_name: Embolism, Tumor


subject: UNII:ZT62XSC86F

object_name: Neoplasm Metastasis


subject: UMLS:C5667055

subject_name: Evalstotug


subject: UMLS:C5667055


subject: UMLS:C5667055


subject: UMLS:C5667055


subject: UMLS:C5667055


subject: UMLS:C5667055


subject: UMLS:C5667055


subject: UMLS:C5667055


subject: UNII:BPM6YN0KLI

subject_name: OZURIFTAMAB VEDOTIN


subject: UNII:BPM6YN0KLI


subject: UNII:BPM6YN0KLI


subject: UNII:BPM6YN0KLI


subject: UNII:BPM6YN0KLI


subject: UNII:BPM6YN0KLI


subject: UNII:BPM6YN0KLI


subject: UNII:BPM6YN0KLI


subject: UMLS:C4733657

subject_name: ADC BA3021


subject: UMLS:C4733657


subject: UMLS:C4733657


subject: UMLS:C4733657


subject: UMLS:C4733657


subject: UMLS:C4733657


subject: UMLS:C4733657


subject: UMLS:C4733657


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: splenic marginal zone lymphoma


subject: CHEBI:91397

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:6801

subject_name: Metformin

object_name: Fanconi anemia


subject: CHEBI:6801

object_name: Fanconi anemia complementation group A


subject: UMLS:C1704263

subject_name: green tea extract

object_name: bipolar disorder


subject: UMLS:C1704263

object_name: schizophrenia


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: DRUGBANK:DB14307


subject: UMLS:C4329513

object_name: aggressive B-cell non-Hodgkin lymphoma


subject: UMLS:C4329513

object_name: indolent B-cell non-Hodgkin lymphoma


subject: UMLS:C4329513

object_name: Refractory Aggressive B-Cell Non-Hodgkin Lymphoma


subject: UMLS:C4329513

object_name: composite lymphoma


subject: UMLS:C4329513

object_name: Mantle cell lymphoma refractory


subject: UMLS:C4329513

object_name: High grade B-cell lymphoma refractory


subject: UMLS:C4329513

object_name: Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UMLS:C4329513

object_name: Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UMLS:C4329513

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: UMLS:C4329513

object_name: Marginal zone lymphoma stage III


subject: UMLS:C4329513

object_name: Follicular lymphoma refractory


subject: UMLS:C4329513

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: UMLS:C4329513

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: UMLS:C4329513

object_name: Marginal zone lymphoma refractory


subject: UMLS:C4329513

object_name: Marginal zone lymphoma stage IV


subject: UMLS:C4329513

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UMLS:C4329513

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UMLS:C4329513

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UMLS:C4329513

object_name: Refractory Grade 3b Follicular Lymphoma


subject: UMLS:C4329513

object_name: Richter syndrome


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: aggressive B-cell non-Hodgkin lymphoma


subject: CHEBI:63791

object_name: Refractory Aggressive B-Cell Non-Hodgkin Lymphoma


subject: CHEBI:63791

object_name: composite lymphoma


subject: CHEBI:63791

object_name: High grade B-cell lymphoma refractory


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6

object_name: Refractory Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:63629

subject_name: Tizanidine

object_name: major depressive disorder


subject: UMLS:C2001392

object_name: osteoarthritis


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: metastatic squamous cell carcinoma


subject: UNII:PQX0D8J21J

object_name: Recurrent squamous cell carcinoma


subject: UNII:PQX0D8J21J

object_name: Neoplasm Recurrence, Local


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib


subject: PUBCHEM.COMPOUND:139350422


subject: PUBCHEM.COMPOUND:139350422

object_name: squamous cell carcinoma


subject: PUBCHEM.COMPOUND:139350422

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:139350422

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:139350422


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: UNII:KC2JC2ZA04


subject: CHEBI:3011

subject_name: Benazepril

object_name: Renal alteration


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Leukokeratosis


subject: UMLS:C2346820


subject: UMLS:C3658590

object_name: asthma


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: traumatic encephalopathy


subject: UMLS:C4305940

object_name: HIV-1 infection


subject: CHEBI:77319

subject_name: Oltipraz

object_name: lung cancer


subject: CHEBI:77319

object_name: lung neoplasm


subject: CHEBI:77319

object_name: lung carcinoma


subject: CHEBI:38940

subject_name: Sunitinib

object_name: metastatic colorectal cancer


subject: UMLS:C5239500

subject_name: Microbiome-derived Peptide Vaccine EO2401

object_name: adrenal carcinoma


subject: UMLS:C5239500

object_name: adrenal cortex carcinoma


subject: UMLS:C5239500

object_name: adrenal gland pheochromocytoma


subject: UMLS:C5239500

object_name: pheochromocytoma


subject: UMLS:C5239500

object_name: paraganglioma


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: Urinary Urgency


subject: PUBCHEM.COMPOUND:21628493

object_name: postmenopausal disorder


subject: PUBCHEM.COMPOUND:21628493

object_name: Urination Disorders


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: CHEBI:50114


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: CHEBI:4903


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: UMLS:C2936882


subject: UMLS:C2936882


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: Malignant neoplasm of stomach stage IV


subject: PUBCHEM.COMPOUND:5281767

object_name: Stage IIIA Gastric Carcinoma


subject: PUBCHEM.COMPOUND:5281767

object_name: Stage IIIB Gastric Carcinoma


subject: PUBCHEM.COMPOUND:5281767

object_name: Stage IV Esophageal Cancer AJCC v6


subject: PUBCHEM.COMPOUND:5281767

object_name: Stage IV Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:5281767

object_name: stage IV esophageal cancer


subject: PUBCHEM.COMPOUND:5281767

object_name: Stage III Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:5281767

object_name: Stage III Esophageal Cancer


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: bipolar disorder


subject: CHEBI:17925

object_name: Bipolar Disorder Type 1


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17234

subject_name: D-glucose


subject: CHEBI:17234


subject: CHEBI:17087

subject_name: ketone


subject: CHEBI:17087


subject: CHEBI:15407

subject_name: Ephedrine

object_name: anesthesia; adverse effect, spinal and epidural


subject: UMLS:C4722369

object_name: rectal carcinoma


subject: UMLS:C4722369

object_name: rectal cancer


subject: UMLS:C4722369

object_name: Childhood Rectal Carcinoma


subject: CHEBI:16302

object_name: Intrinsic aging of skin


subject: CHEBI:50211

subject_name: retinol


subject: CHEBI:45479


subject: UMLS:C0087161

subject_name: all-trans-retinol


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:3561

subject_name: Cetirizine

object_name: asthma


subject: CHEBI:90841

subject_name: Cangrelor

object_name: Acute non-ST segment elevation myocardial infarction (disorder)


subject: UMLS:C2826137

object_name: cancer


subject: UMLS:C2826137

object_name: neoplasm


subject: UMLS:C2826137

object_name: Primary malignant neoplasm


subject: UMLS:C2826137

object_name: carcinoma


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: UMLS:C0003442

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UMLS:C0003442

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0003442

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0003442

object_name: Stage I Adult Immunoblastic Lymphoma


subject: UMLS:C0003442

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0003442

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: UMLS:C0003442

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0003442

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C0003442

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C0003442

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: UMLS:C0003442

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: UMLS:C0003442

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: UMLS:C0003442

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UMLS:C0003442

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: UMLS:C0003442

object_name: Mantle cell lymphoma stage I


subject: UMLS:C0003442

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: UMLS:C0003442

object_name: Mycosis fungoides/Sezary syndrome stage II


subject: UMLS:C0003442

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: UMLS:C0003442

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: UMLS:C0003442

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: UMLS:C0003442

object_name: Cutaneous T-cell lymphoma stage II


subject: UMLS:C0003442

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C0003442

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UMLS:C0003442

object_name: Adult T-cell lymphoma/leukaemia stage II


subject: UMLS:C0003442

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: UMLS:C0003442

object_name: Cutaneous T-cell lymphoma stage IV


subject: UMLS:C0003442

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: UMLS:C0003442

object_name: Mycosis fungoides/Sezary syndrome stage I


subject: UMLS:C0003442

object_name: Cutaneous T-cell lymphoma stage I


subject: UMLS:C0003442

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: UMLS:C0003442

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: UMLS:C0003442

object_name: Adult T-cell lymphoma/leukaemia stage I


subject: UMLS:C0003442

object_name: B-cell small lymphocytic lymphoma stage I


subject: UMLS:C0003442

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: UMLS:C0003442

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: UMLS:C0003442

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: UMLS:C0003442

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: UMLS:C0003442

object_name: Stage III Adult Burkitt Lymphoma


subject: UMLS:C0003442

object_name: Marginal zone lymphoma stage I


subject: UMLS:C0003442

object_name: Stage I Adult Burkitt Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:174615

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:174615

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:174615

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:174615

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:174615

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:174615

object_name: Stage I Adult Immunoblastic Lymphoma


subject: CHEBI:174615

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:174615

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:174615

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:174615

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:174615

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:174615

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:174615

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:174615

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:174615

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:174615

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:174615

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:174615

object_name: Mantle cell lymphoma stage III


subject: CHEBI:174615

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:174615

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:174615

object_name: Mantle cell lymphoma stage I


subject: CHEBI:174615

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:174615

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:174615

object_name: Mycosis fungoides/Sezary syndrome stage II


subject: CHEBI:174615

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:174615

object_name: Cutaneous T-cell lymphoma stage II


subject: CHEBI:174615

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:174615

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: CHEBI:174615

object_name: Adult T-cell lymphoma/leukaemia stage II


subject: CHEBI:174615

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: CHEBI:174615

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:174615

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:174615

object_name: Mycosis fungoides/Sezary syndrome stage I


subject: CHEBI:174615

object_name: Cutaneous T-cell lymphoma stage I


subject: CHEBI:174615

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: CHEBI:174615

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:174615

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:174615

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:174615

object_name: Adult T-cell lymphoma/leukaemia stage I


subject: CHEBI:174615

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:174615

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:174615

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:174615

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:174615

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:174615

object_name: Marginal zone lymphoma stage III


subject: CHEBI:174615

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:174615

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:174615

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:174615

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:174615

object_name: Marginal zone lymphoma stage I


subject: CHEBI:174615

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:174615

object_name: Stage I Adult Burkitt Lymphoma


subject: CHEBI:28901

subject_name: Busulfan

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:28901

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28901

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28901

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28901

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28901

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:28901

object_name: Stage I Adult Immunoblastic Lymphoma


subject: CHEBI:28901

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:28901

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28901

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28901

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:28901

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:28901

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28901

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28901

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28901

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:28901

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:28901

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:28901

object_name: Mantle cell lymphoma stage III


subject: CHEBI:28901

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:28901

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:28901

object_name: Mantle cell lymphoma stage I


subject: CHEBI:28901

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:28901

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:28901

object_name: Mycosis fungoides/Sezary syndrome stage II


subject: CHEBI:28901

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:28901

object_name: Cutaneous T-cell lymphoma stage II


subject: CHEBI:28901

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:28901

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: CHEBI:28901

object_name: Adult T-cell lymphoma/leukaemia stage II


subject: CHEBI:28901

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: CHEBI:28901

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:28901

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:28901

object_name: Mycosis fungoides/Sezary syndrome stage I


subject: CHEBI:28901

object_name: Cutaneous T-cell lymphoma stage I


subject: CHEBI:28901

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: CHEBI:28901

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:28901

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:28901

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: CHEBI:28901

object_name: Adult T-cell lymphoma/leukaemia stage I


subject: CHEBI:28901

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:28901

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:28901

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: CHEBI:28901

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:28901

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: CHEBI:28901

object_name: Marginal zone lymphoma stage III


subject: CHEBI:28901

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:28901

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:28901

object_name: Stage III Adult Burkitt Lymphoma


subject: CHEBI:28901

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:28901

object_name: Marginal zone lymphoma stage I


subject: CHEBI:28901

object_name: Stage IV Adult Burkitt Lymphoma


subject: CHEBI:28901

object_name: Stage I Adult Burkitt Lymphoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:4026

object_name: Mycosis fungoides/Sezary syndrome stage II


subject: CHEBI:4026

object_name: Cutaneous T-cell lymphoma stage II


subject: CHEBI:4026

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:4026

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Adult T-cell lymphoma/leukaemia stage II


subject: CHEBI:4026

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:4026

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:4026

object_name: Mycosis fungoides/Sezary syndrome stage I


subject: CHEBI:4026

object_name: Cutaneous T-cell lymphoma stage I


subject: CHEBI:4026

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: CHEBI:4026

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:4026

object_name: Adult T-cell lymphoma/leukaemia stage I


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UNII:4F4X42SYQ6

object_name: Adult Acute Myeloid Leukemia in Remission


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6

object_name: recurrent adult acute myeloid leukemia


subject: UNII:4F4X42SYQ6

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: UNII:4F4X42SYQ6

object_name: Previously Treated Myelodysplastic Syndrome


subject: UNII:4F4X42SYQ6

object_name: Secondary Myelodysplastic Syndrome


subject: UNII:4F4X42SYQ6

object_name: De Novo Myelodysplastic Syndrome


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Mycosis fungoides/Sezary syndrome stage II


subject: CHEBI:61057

object_name: Cutaneous T-cell lymphoma stage II


subject: CHEBI:61057

object_name: Stage III Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61057

object_name: Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: CHEBI:61057

object_name: Adult T-cell lymphoma/leukaemia stage II


subject: CHEBI:61057

object_name: Cutaneous T-cell lymphoma stage IV


subject: CHEBI:61057

object_name: Mycosis fungoides/Sezary syndrome stage IV


subject: CHEBI:61057

object_name: Mycosis fungoides/Sezary syndrome stage I


subject: CHEBI:61057

object_name: Cutaneous T-cell lymphoma stage I


subject: CHEBI:61057

object_name: Adult T-cell lymphoma/leukaemia stage III


subject: CHEBI:61057

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:61057

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: CHEBI:61057

object_name: Adult T-cell lymphoma/leukaemia stage I


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: UNII:T41737F88A

subject_name: Tisotumab vedotin

object_name: ovarian carcinoma


subject: UNII:T41737F88A

object_name: peritoneum cancer


subject: UNII:T41737F88A

object_name: fallopian tube carcinoma


subject: UNII:T41737F88A

object_name: fallopian tube cancer


subject: UMLS:C3827178

subject_name: HuMax-TF-ADC


subject: UMLS:C3827178


subject: UMLS:C3827178


subject: UMLS:C3827178


subject: CHEBI:7726

subject_name: octreotide

object_name: gastric neuroendocrine tumor, well differentiated, low or intermediate grade


subject: CHEBI:7726

object_name: gastric neuroendocrine neoplasm


subject: UNII:25E79B5CTM

subject_name: Denileukin diftitox

object_name: B-cell neoplasm


subject: UMLS:C0211023


subject: MESH:C568346

subject_name: ClinOleic

object_name: Insulin Sensitivity


subject: MESH:C568346

object_name: metabolic disease


subject: CHEBI:17925

subject_name: alpha-D-glucose


subject: CHEBI:17925


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17634

subject_name: D-glucose


subject: CHEBI:17634


subject: CHEBI:17234


subject: CHEBI:17234


subject: CHEBI:166975

subject_name: soybean oil


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: CHEBI:60799

subject_name: Esketamine

object_name: kidney failure


subject: UMLS:C2830035

object_name: type 2 diabetes mellitus


subject: UMLS:C2830035

object_name: maturity-onset diabetes of the young type 1


subject: CHEBI:6078

subject_name: Ivermectin

object_name: Parosmia


subject: CHEBI:9241

subject_name: Spironolactone

object_name: bronchopulmonary dysplasia


subject: CHEBI:9241

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:9241

object_name: Chronic lung disease


subject: CHEBI:33372

subject_name: Neodymium

object_name: Nerve root pain NEC


subject: CHEBI:33372

object_name: dental pulp disorder


subject: CHEBI:33372

object_name: dental pulp necrosis


subject: CHEBI:73419

subject_name: Asn-Asp


subject: CHEBI:73419


subject: CHEBI:73419


subject: CHEBI:4911

subject_name: Etoposide

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:4911

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]


subject: UMLS:C5848866


subject: UMLS:C5848866

object_name: non-Hodgkin lymphoma


subject: UMLS:C5848866

object_name: Myelodysplasia


subject: UMLS:C5848866

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C5848866

object_name: childhood myelodysplastic syndrome


subject: UMLS:C5848866

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C5848866

object_name: acute lymphoblastic leukemia


subject: GTOPDB:4985


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: colon cancer liver metastasis


subject: UMLS:C3641122


subject: DRUGBANK:DB16460

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: DRUGBANK:DB16460

object_name: acute respiratory distress syndrome


subject: DRUGBANK:DB16460

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: DRUGBANK:DB16460

object_name: adult acute respiratory distress syndrome


subject: DRUGBANK:DB16460


subject: DRUGBANK:DB16460

object_name: severe acute respiratory syndrome


subject: DRUGBANK:DB16460

object_name: Coronavinae infectious disease


subject: CHEBI:61917

subject_name: (R)-thalidomide

object_name: plasma cell myeloma


subject: CHEBI:61918

subject_name: (S)-thalidomide


subject: UMLS:C0971122

subject_name: ICL 670A

object_name: sickle cell disease


subject: PR:000007470

subject_name: vacuolar protein sorting-associated protein 51

object_name: myocardial ischemia


subject: PR:000007470

object_name: coronary atherosclerosis


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Increased reactive oxygen species production


subject: CHEBI:58779

object_name: methamphetamine dependence


subject: CHEBI:49086


subject: CHEBI:16436

subject_name: Citicoline


subject: UNII:WKM56H3TLB

subject_name: Myrcludex B

object_name: chronic hepatitis B virus infection


subject: UNII:WKM56H3TLB

object_name: hepatitis B


subject: UNII:JA8K50N04H

subject_name: MYRCLUDEX B


subject: UNII:JA8K50N04H


subject: UMLS:C3491973

subject_name: myrcludex-B


subject: UMLS:C3491973


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: skin melanoma


subject: CHEBI:93786


subject: CHEBI:36333

subject_name: local anaesthetic

object_name: dental pulp disorder


subject: CHEBI:36333

object_name: Symptomatic irreversible pulpitis


subject: UMLS:C3536836

subject_name: Local Anesthetic [EPC]


subject: UMLS:C3536836


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: malignant mesothelioma


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: cancer


subject: CHEBI:5801

object_name: neoplasm


subject: UMLS:C4744853

object_name: Childhood Solid Neoplasm


subject: UMLS:C4744853

object_name: Adult Solid Neoplasm


subject: UMLS:C4744853

object_name: Solid Neoplasm


subject: UMLS:C4744853

object_name: HER2 gene amplification


subject: UMLS:C4744853

object_name: Rare Diseases


subject: UMLS:C4744853

object_name: skin neoplasm


subject: UMLS:C4744853

object_name: skin cancer


subject: UMLS:C4744853

object_name: lung cancer


subject: UMLS:C4744853

object_name: lung neoplasm


subject: UMLS:C4744853

object_name: lung carcinoma


subject: UMLS:C4744853

object_name: ERBB2 Gene Mutation


subject: UMLS:C4744853

object_name: oral cavity carcinoma


subject: UMLS:C4744853

object_name: oral cavity cancer


subject: UMLS:C4744853

object_name: liver cancer


subject: UMLS:C4744853

object_name: liver neoplasm


subject: UMLS:C4744853

object_name: Adult Liver Carcinoma


subject: UMLS:C4744853

object_name: liver carcinoma


subject: UMLS:C4744853

object_name: tonsil carcinoma


subject: UMLS:C4744853

object_name: tonsil cancer


subject: UMLS:C4744853

object_name: Malignant tumor of palate


subject: UMLS:C4744853

object_name: rectal carcinoma


subject: UMLS:C4744853

object_name: rectal cancer


subject: UMLS:C4744853

object_name: Childhood Rectal Carcinoma


subject: UMLS:C4744853

object_name: tongue cancer


subject: UMLS:C4744853

object_name: tongue carcinoma


subject: UMLS:C4744853

object_name: laryngeal carcinoma


subject: UMLS:C4744853

object_name: larynx cancer


subject: UMLS:C4744853

object_name: malignant neoplasm of lip stage I


subject: UMLS:C4744853

object_name: prostate carcinoma


subject: UMLS:C4744853

object_name: prostate cancer


subject: UMLS:C4744853

object_name: pancreatic neoplasm


subject: UMLS:C4744853

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4744853

object_name: malignant pancreatic neoplasm


subject: UMLS:C4744853

object_name: bladder tumor


subject: UMLS:C4744853

object_name: urinary bladder carcinoma


subject: UMLS:C4744853

object_name: urinary bladder cancer


subject: UMLS:C4744853

object_name: childhood bladder carcinoma


subject: UMLS:C4744853

object_name: Stage III Rectal Cancer AJCC v6


subject: UMLS:C4744853

object_name: Stage II Rectal Cancer


subject: UMLS:C4744853

object_name: Rectal cancer stage I


subject: UMLS:C4744853

object_name: Stage I Rectal Cancer AJCC v6 and v7


subject: UMLS:C4744853

object_name: cervical cancer


subject: UMLS:C4744853

object_name: cervical carcinoma


subject: UMLS:C4744853

object_name: malignant urinary system neoplasm


subject: UMLS:C4744853

object_name: tumor of salivary gland


subject: UMLS:C4744853

object_name: salivary gland cancer


subject: UMLS:C4744853

object_name: bile duct carcinoma


subject: UMLS:C4744853

object_name: bile duct cancer


subject: UMLS:C4744853

object_name: cholangiocarcinoma


subject: UMLS:C4744853

object_name: colorectal carcinoma


subject: UMLS:C4744853

object_name: Colon cancer recurrent


subject: UMLS:C4744853

object_name: Prostate cancer recurrent


subject: UMLS:C4744853

object_name: Renal cell carcinoma recurrent


subject: UMLS:C4744853

object_name: Renal cancer recurrent


subject: UMLS:C4744853

object_name: Mucinous breast cancer recurrent


subject: UMLS:C4744853

object_name: Breast cancer recurrent


subject: UMLS:C4744853

object_name: Neck Carcinoma


subject: UMLS:C4744853

object_name: head and neck neoplasm


subject: UMLS:C4744853

object_name: head and neck cancer


subject: UMLS:C4744853

object_name: HER2-positive gastric cancer


subject: UMLS:C4744853

object_name: recurrent gastric cancer


subject: UMLS:C4744853

object_name: salivary gland carcinoma


subject: UMLS:C4744853

object_name: HER2 positive breast carcinoma


subject: UMLS:C4744853

object_name: mucoepidermoid carcinoma


subject: UMLS:C4744853

object_name: Primary malignant neoplasm of breast


subject: UMLS:C4744853

object_name: mucinous gastric adenocarcinoma


subject: UMLS:C4744853

object_name: Recurrent ovarian cancer


subject: UMLS:C4744853

object_name: primary peritoneal carcinoma


subject: UMLS:C4744853

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C4744853

object_name: peritoneal carcinoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: IDH-mutant and 1p/19q-codeleted oligodendroglioma


subject: CHEBI:72564

subject_name: Temozolomide


subject: UMLS:C4083270

subject_name: BIBW 2992

object_name: squamous cell carcinoma


subject: UMLS:C4083270


subject: CHEBI:47458

subject_name: Saracatinib

object_name: lymphangioleiomyomatosis


subject: CHEBI:47458

object_name: lung lymphangioleiomyomatosis


subject: UMLS:C4289971

subject_name: Anti-PD-L1 Monoclonal Antibody

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4289971

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab


subject: UNII:T4H8FMA7IM


subject: GTOPDB:8221

subject_name: epacadostat

object_name: mucosal melanoma


subject: GTOPDB:8221

object_name: stage IIIC melanoma


subject: GTOPDB:8221

object_name: stage IIIB melanoma


subject: GTOPDB:8221

object_name: stage IIIA melanoma


subject: GTOPDB:8221

object_name: Stage IIIB Uveal Melanoma AJCC v7


subject: GTOPDB:8221

object_name: Stage IIIA Uveal Melanoma AJCC v7


subject: GTOPDB:8221

object_name: Stage IIIC Uveal Melanoma AJCC v7


subject: GTOPDB:8221

object_name: Melanoma recurrent


subject: GTOPDB:8221

object_name: Stage IV Uveal Melanoma AJCC v7


subject: GTOPDB:8221

object_name: Recurrent Uveal Melanoma


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UNII:2HR315841W


subject: UMLS:C2987391

subject_name: MELITAC 12.1 Peptide Vaccine


subject: UMLS:C2987391


subject: UMLS:C2987391


subject: UMLS:C2987391


subject: UMLS:C2987391


subject: UMLS:C2987391


subject: UMLS:C2987391


subject: UMLS:C2987391


subject: UMLS:C2987391


subject: UMLS:C2987391


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: digestive system neoplasm


subject: UNII:P0GVQ9A4S5

object_name: Neoplasm of the gastrointestinal tract


subject: UNII:P0GVQ9A4S5

object_name: cancer


subject: UNII:P0GVQ9A4S5

object_name: gastric neoplasm


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UNII:CBF5R8TXD9


subject: UNII:CBF5R8TXD9


subject: UNII:CBF5R8TXD9


subject: UNII:CBF5R8TXD9


subject: UNII:CBF5R8TXD9

object_name: neoplasm


subject: UMLS:C5853355


subject: UMLS:C5853355


subject: UMLS:C5853355


subject: UMLS:C5853355


subject: UMLS:C5853355


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: liver disorder


subject: CHEBI:46195

object_name: Acetaminophen causing adverse effects in therapeutic use


subject: UMLS:C5238921

subject_name: PRMT5 Inhibitor PRT811

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5238921

object_name: Recurrent Glioma


subject: CHEBI:50381

subject_name: Miglustat

object_name: Niemann-Pick disease, type C1


subject: KEGG.COMPOUND:C02380

object_name: Refractory acute myeloid leukemia


subject: KEGG.COMPOUND:C02380

object_name: Relapsing acute myeloid leukemia


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:91435

subject_name: Linifanib

object_name: Advanced Hepatocellular Carcinoma


subject: UMLS:C1738762

subject_name: ABT 869


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: meningitis


subject: CHEBI:6770

object_name: Meningitis, CTCAE


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: UMLS:C1314417


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: dyspepsia


subject: PUBCHEM.COMPOUND:53477758

object_name: Dyspepsia, CTCAE


subject: PUBCHEM.COMPOUND:53477758

object_name: Lack of satiety


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: UMLS:C0592155


subject: UMLS:C0796606

subject_name: DTGM Fusion Protein

object_name: leukemia


subject: UMLS:C0796606

object_name: childhood leukemia


subject: UMLS:C5666978

subject_name: Anti-TIGIT Monoclonal Antibody BAT6021

object_name: Childhood Solid Neoplasm


subject: UMLS:C5666978

object_name: Adult Solid Neoplasm


subject: UMLS:C5666978

object_name: Solid Neoplasm


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Anemia of pregnancy


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: gastric adenocarcinoma


subject: UNII:52CMI0WC3Y

object_name: Adenocarcinoma, metastatic


subject: UNII:52CMI0WC3Y

object_name: Advanced gastric carcinoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:95089

subject_name: Ipatasertib


subject: CHEBI:95089


subject: CHEBI:95089

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:95089


subject: RXCUI:616538

subject_name: omeprazole / sodium bicarbonate Oral Capsule

object_name: Heartburn


subject: RXCUI:616538

object_name: Barrett esophagus


subject: CHEBI:49200

subject_name: EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor


subject: UMLS:C3536754

subject_name: Proton Pump Inhibitor [EPC]


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: keloid


subject: UMLS:C5789747

subject_name: Kavalactones

object_name: Stress


subject: UMLS:C5565871

subject_name: Paxlovid


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: diabetic kidney disease


subject: CHEMBL.COMPOUND:CHEMBL5314347

subject_name: SEVELAMER CARBONATE


subject: UNII:9YCX42I8IU

subject_name: sevelamer carbonate


subject: CHEBI:177770

subject_name: Ganetespib

object_name: Plexosarcoma


subject: CHEBI:142708

object_name: Community-Acquired Pneumonia


subject: CHEBI:142708

object_name: bacterial pneumonia


subject: PUBCHEM.COMPOUND:54686904

subject_name: tigecycline


subject: PUBCHEM.COMPOUND:54686904


subject: CHEBI:149836

subject_name: Tigecycline


subject: CHEBI:31824

subject_name: Mesna

object_name: brain neoplasm


subject: CHEBI:31824

object_name: central nervous system neoplasm


subject: CHEBI:31824

object_name: central nervous system cancer


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:17905


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Restless legs


subject: CHEBI:45783

subject_name: Imatinib

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: CHEBI:45783

object_name: colorectal neoplasm


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: CHEBI:63635

subject_name: Valganciclovir

object_name: immune reconstitution inflammatory syndrome


subject: CHEBI:63635

object_name: Immune reconstitution syndrome


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: Severe uncontrolled persistent asthma


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: subarachnoid hemorrhage


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Smell Dysfunction


subject: CHEBI:27470

subject_name: Folic acid

object_name: Childhood Breast Carcinoma


subject: CHEBI:27470

object_name: breast carcinoma


subject: CHEBI:27470

object_name: breast cancer


subject: CHEBI:27470

object_name: breast neoplasm


subject: CHEBI:27470

object_name: Mammary Carcinoma, Human


subject: UMLS:C5203275

subject_name: Pralatrexate Liquid Injection


subject: UMLS:C5203275


subject: UMLS:C5203275


subject: UMLS:C5203275


subject: UMLS:C5203275


subject: UMLS:C2959279

subject_name: Injection, pralatrexate, 1 mg


subject: UMLS:C2959279


subject: UMLS:C2959279


subject: UMLS:C2959279


subject: UMLS:C2959279


subject: CHEBI:71223

subject_name: Pralatrexate


subject: CHEBI:71223


subject: CHEBI:71223


subject: CHEBI:71223


subject: CHEBI:71223


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: CHEBI:28911


subject: CHEBI:28911


subject: CHEBI:28911


subject: CHEBI:28911


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: PUBCHEM.COMPOUND:165339223


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: HMDB:HMDB0000607


subject: CHEBI:176843

subject_name: vitamin B12


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: CHEBI:176843


subject: UMLS:C0086024

subject_name: cobalamins


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: UMLS:C0086024


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: UMLS:C2936883


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Primary bacterial peritonitis


subject: CHEBI:3441

object_name: acute spontaneous bacterial peritonitis


subject: CHEBI:3441

object_name: hepatic encephalopathy


subject: CHEBI:3441

object_name: Ascites


subject: CHEBI:3441

object_name: Ascites, CTCAE


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:8499


subject: CHEBI:58097

object_name: Opioid withdrawal


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:8884

subject_name: Rocuronium

object_name: Hypothermia due to exposure


subject: CHEBI:8884

object_name: Hypothermia


subject: CHEBI:8884

object_name: Hypothermia, CTCAE


subject: CHEBI:8884

object_name: Cardiac arrest with successful resuscitation


subject: CHEBI:8884

object_name: Skeletal muscle relaxant overdose